CTIS2022-502224-49-00招募中1 期
Human papillomavirus vaccine effectiveness study among men who have sex with men
Geneeskundige En Gezondheidsdienst Amsterdam0 个研究点目标入组 730 人开始时间: 2022年11月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 730
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- Male
入选标准
- •(Group 1, recruited at baseline) Being male and reporting sex with other men in preceding 6 months, (Group 2, recruited month 24) Being male and reporting sex with other men in the preceding 6 months, (Group 2, recruited month 24) Age 21-28 years, (Group 2, recruited month 24) Attending the Sexual Health Clinic in Amsterdam, (Group 2, recruited month 24) Accepting hypothetically prophylactic HPV vaccination, (Group 2, recruited month 24) Providing informed consent, (Group 1, recruited at baseline) Age 19-26 years, (Group 1, recruited at baseline) Attending the SHC in Amsterdam, (Group 1, recruited at baseline) Accepting prophylactic HPV vaccination, (Group 1, recruited at baseline) Planning to stay in or around Amsterdam over the next two years, (Group 1, recruited at baseline) Willing and able to return for 1 subsequent visit for vaccination, (Group 1, recruited at baseline) Willing and able to complete an online questionnaire at month 15, (Group 1, recruited at baseline) Willing and able to return for a month 24 final study visit, (Group 1, recruited at baseline) Providing informed consent
排除标准
- •(Group 1 & 2) Having been vaccinated with one or more doses of any of the HPV vaccines, (Group 1 & 2) Not able to read/understand Dutch or English, (Group 1 & 2) Previous enrolment in the study, (Group 1 & 2) History of anal cancer or anal intraepithelial neoplasia (AIN), (Group 1 & 2) Unlikely to adhere to the study protocol, (Group 1 & 2) Allergy to one or more components of the vaccine
研究者
相似试验
尚未招募
Unknown
Effectiveness of Human Papilloma Virus vaccine health education on knowledge, attitude and practice among school going students of two schools in Manipur: A Non-Randomized Control TrialCTRI/2024/02/063161Sneha Dhali
已完成
不适用
The Canadian Cervical Cancer Screening Trial of human papillomavirus (HPV) testing versus Pap cytologyCancerISRCTN57612064McGill University (Canada) - Research Grants Office10,154
进行中（未招募）
1 期
Human papillomavirus (HPV) vaccination for treatment of premalignant skin lesionsActinic Keratosis (AK)MedDRA version: 20.0Level: HLTClassification code 10052567Term: Skin preneoplastic conditions NECSystem Organ Class: 100000004858MedDRA version: 20.0Level: HLTClassification code 10040901Term: Skin neoplasms malignant and unspecified (excl melanoma)System Organ Class: 100000004858EUCTR2021-003895-15-DKBispebjerg Hospital, Department of Dermatology and Venereology70
已完成
不适用
Immunogenicity and duration of immunity in immunosuppressed children vaccinated with Human papillomavirus vaccineACTRN12608000260325The Children's Hospital at Westmead59
招募中
不适用
The efficacy evaluation of the human papillomavirus (HPV) testing in primary cervix cancer screeningCervix cancerJPRN-UMIN000014720School of Medicine, Keio University50,000